Morphology, mechanisms and pathology of musculoskeletal ageing

Journal of Pathology

Volumn 211, Issue 2, 2007, Pages 252-259

  Freemont, A J ^a   Hoyland, J A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Ageing; Bone; Cartilage; Cell biology; Intervertebral disc; Ligament; Matrix; Musculoskeletal

Indexed keywords

COLLAGEN; CYTOKINE; ELASTIN; GROWTH HORMONE; PROTEOGLYCAN; SOMATOMEDIN;

AGING; APOPTOSIS; ARTICULAR CARTILAGE; BONE MASS; CELL POPULATION; CHONDROPATHY; CONNECTIVE TISSUE CELL; CONNECTIVE TISSUE DISEASE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FALL RISK; FRACTURE; FRAGILITY FRACTURE; FUNCTIONAL DISEASE; GERIATRIC DISORDER; HEMATOPOIETIC STEM CELL; HIGH RISK PATIENT; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LIFESTYLE; LIGAMENT DISEASE; MECHANOTRANSDUCTION; MESENCHYMAL STEM CELL; MUSCLE ISCHEMIA; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYOPATHY; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE;

ADULT STEM CELLS; AGING; APOPTOSIS; BONE AND BONES; CARTILAGE, ARTICULAR; CELL AGING; COLLAGEN; CONNECTIVE TISSUE; CYTOKINES; GONADAL STEROID HORMONES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISCHEMIA; MUSCLE, SKELETAL; MUSCULOSKELETAL PHYSIOLOGY; PROTEOGLYCANS; STRESS, MECHANICAL;

EID: 33846699802     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2097     Document Type: Review

References (88)

1. Rehman MTA, Hoyland JA, Denton J, Freemont AJ. Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 1994;47(6):529-534.
2. Khosla S, Riggs BL. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am 2005;34(4):1015-1030.
3. Freemont AJ. The pathophysiology of cartilage and synovium. Br J Rheumatol 1996;35(suppl 3):10-13.
4. Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy. J Pathol 2002;196(4):374-379.
5. Iannone F, Lapadula G. The pathophysiology of osteoarthritis. Aging Clin Exp Res 2003;15(5):364-372.
6. Barros EM, Rodrigues CJ, Rodrigues NR, Oliveira RP, Barros TE, Rodrigues AJ, Jr. Aging of the elastic and collagen fibers in the human cervical interspinous ligaments. Spine J 2002;2(1):57-62.
7. Sargon MF, Doral MN, Atay OA. Age-related changes in human PCLs: a light and electron microscopic study. Knee Surg Sports Traumatol Arthrosc 2004;12(4):280-284.
8. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 1988;84(2-3):275-294.
9. Goldspink G, Harridge SDR. Growth factors and muscle ageing. Exp Gerontol 2004;39(10):1433-1438.
10. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003;6(3):295-299.
11. Toth MJ, Tchernof A. Lipid metabolism in the elderly. Eur J Clin Nutr 2000;54(suppl 3):S121-125.
12. Kirkland JL, Dobson DE. Preadipocyte function and aging: links between age-related changes in cell dynamics and altered fat tissue function, J Am Geriatr Soc 1997;45(8):959-967.
13. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I. Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol 2002;37(6):757-767.
14. Bailey AJ, Paul RG, Knott L. Mechanism of maturation and ageing of collagen. Mech Ageing Dev 1998;106(1-2):1-56.
15. Fujimoto D, Ishida T, Hayashi H. The structure of pyridinoline, a collagen cross-link. Biochem Biophys Res Commun 1978;84(1):52-57.
16. Kuypers R, Tyler M, Kurth LB, Jenkins ID, Horgan DJ. Identification of the loci of the collagen-associated Ehrlich chromagen in type I collagen confirms its role as a trivalent cross-link. Biochem J 1992;283(1):129-136.
17. Knott L, Bailey AJ. Collagen cross-links in mineralising tissue: a review of theirchemistry, function and clinical relevance. Bone 1998;22(3):181-187.
18. Kohn RR, Cerami A, Monnier VM. Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes 1984;33(1): 57-59.
19. Baynes JW. The role of oxidative stress in the development of complications in diabetes. Diabetes 1991;40(4):405-412.
20. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end-products induce sclerosis and albuminurea in normal rats. Proc Natl Acad Sci USA 1994;91(24): 11704-11708.
21. Paul RG, Bailey AJ. The effect of advanced glycation end-product formation upon cell-matrix interactions. Int J Biochem Cell Biol 1999;31(6):653-660.
22. Winlove CP, Parker KH, Avery NC, Bailey AJ. Interactions of elastin and aorta with sugars in vitro and their effects on the biochemical and physical properties. Diabetologia 1996;39(10):1131-1139.
23. Scott JE. Elasticity in extracellular matrix 'shape modules' of tendon, cartilage, etc. A sliding proteoglycan-filament model. J Physiol 2003;553(2):335-343.
24. Scott JE, Stockwell RA. Cartilage elasticity resides in shape module decoran and aggrecan sumps of damping fluid: implications in osteoarthrosis. J Physiol 2006;574(3):643-650.
25. Martin JA, Buckwalter JA. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002;3(5):257-264.
26. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 2005;62(19-20):2241-2256.
27. Roughley PJ. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine 2004;29(23): 2691-2699.
28. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004;204(1):47-54.
29. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997;56(9):542-549.
30. Carrington JL. Aging bone and cartilage: cross-cutting issues. Biochem Biophys Res Commun 2005;328(3):700-708.
31. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 2001;98(12):6736-6741.
32. Sonntag WE, Lynch CD, Cefalu WT, Ingram RL, Bennett SA, Thornton PL, et al. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. J Gerontol A Biol Sci Med Sci 1999;54(12):B521-B538.
33. Martin JA, Ellerbroek SM, Buckwalter JA. Age-related decline in chondrocyte response to insulin-like growth factor-I: the role of growth factor binding proteins. J Orthop Res 1997;15(4):491-498.
34. Rosen CJ. Growth hormone and aging. Endocrine 2000;12(2): 197-201.
35. Frystyk J. Aging somatotropic axis: mechanisms and implications of insulin-like growth factor-related binding protein adaptation. Endocrinol Metab Clin North Am 2005;34(4):865-876.
36. Lombardi G, Tauchmanova L, Di Somma C, Musella T, Rota F, Savanelli MC, et al. Somatopause: dismetabolic and bone effects. J Endocrinol Invest 2005;28(10 suppl):36-42.
37. Z̧ofková I. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res 2003;52(6):657-679.
38. Wuster C, Harle U, Rehn U, Muller C, Knauf K, Koppler D, et al. Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis. Growth Horm IGF Res 1998;8(suppl A):87-94.
39. Bolton MC, Dudhia J, Bayliss MT. Age-related changes in the synthesis of link protein and aggrecan in human articular cartilage: implications for aggregate stability. Biochem J 1999;337(1):77-82.
40. Loeser RF, Shanker G, Carlson CS, Gardin JF, Shelton BJ, Sonntag WE. Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis: studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 2000;43:2110-2120.
41. Loeser RF, Carlson CS, Del Carlo M, Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-1β and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum 2002;46(9):2349-2357.
42. Sharma A, Lee YB, Murray JD, Oberbauer AM. Skeletal muscle growth of oMTIa-oGH transgenic mice. Growth Dev Aging 1996;60(1):31-41.
43. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323(1): 1-6.
44. McKoy G, Ashley W, Mander J, Yang SY, Williams N, Russell B, et al. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol 1999;516(2):583-592.
45. Hameed M, Lange KHW, Andersen JL, Schjerling P, Kjaer M, Harridge SDR, et al. The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. J Physiol 2004;555(1):231-240.
46. Byers RJ, Hoyland JA, Braidman IP. Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 2001;168(3):353-362.
47. Khosla S, Melton III LJ, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001;86(8):3555-3561.
48. Braidman IP, Baris C, Selby PL, Adams JE, Freemont AJ, Hoyland JA. Preliminary report of impaired oestrogen receptor-alpha expression in bone, but no involvement of androgen receptor, in male idiopathic osteoporosis. J Pathol 2000;192(1):90-96.
49. Braidman IP, Hainey L, Batra G, Selby PL, Saunders PT, Hoyland JA. Localization of estrogen receptor beta protein expression in adult human bone. J Bone Miner Res 2001;16(2):214-220.
50. Batra GS, Hainey L, Freemont AJ, Andrew G, Saunders PT, Hoyland JA, et al. Related evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women. J Pathol 2003;200(1):65-73.
51. Hanna F, Ebeling PR, Wang Y, O'Sullivan R, Davis S, Wluka AE, et al. Factors influencing longitudinal change in knee cartilage volume measured from magnetic resonance imaging in healthy men. Ann Rheum Dis 2005;64(7):1038-1042.
52. Hamlet WP. Liu SH, Panossian V, Finerman GA. Primary immunolocalization of androgen target cells in the human anterior cruciate ligament. J Orthop Res 1997;15(5):657-663.
53. Liu SH, al-Shaikh R, Panossian V, Yang RS, Nelson SD, Soleiman N, et al. Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res 1996;14(4):526-533.
54. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther 2005;7(4):R732-745.
55. Le Maitre CL, Freemont AJ, Hoyland JA. A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration, Int J Exp Pathol 2006;87(1):17-28.
56. Wei J, Xu H, Davies JL, Hemmings GP. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci 1992;51(25):1953-1956.
57. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993;150(12):5219-5230.
58. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006;119(6):526.e9-17.
59. Price JS, Waters JG, Darrah C, Pennington C, Edwards DR, Donell ST, et al. The role of chondrocyte senescence in osteoarthritis. Aging Cell 2002;1(1):57-65.
60. Magalhâes JP. From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing. Exp Cell Res 2004;300(1):1-10.
61. Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 1999;96(25):14276-14281.
62. Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 2000;35(8):927-945.
63. Dai SM, Shan ZZ, Nakamura H, Masuko-Hongo K, Kato T, Nishioka K, et al. Catabolic stress induces features of chondrocyte senescence through over-expression of caveolin 1: possible involvement of caveolin 1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum 2006;54(3):818-831.
64. Park JS, Kim HY, Kim HW, Chae GN, Oh HT, Park JY, et al. Increased caveolin-1, a cause for the declined adipogenic potential of senescent human mesenchymal stem cells. Mech Ageing Dev 2005;126(5):551-559.
65. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 2004;36(4):585-597.
66. Mansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C, et al. Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc 2006;38(3):967-969.
67. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004;4(3):290-294.
68. Byers RJ, Denton J, Hoyland JA, Freemont AJ. Differential patterns of osteoblast dysfunction in trabecular bone in patients with established osteoporosis. J Clin Pathol 1997;50(9):760-764.
69. Nuttall ME, Gimble JM. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 2004;4(3):290-294.
70. Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002;143(6): 2376-2384.
71. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, et al. Inhibition of adipogenesis by Wnt signaling. Science 2000;289(5481):950-953.
72. Conboy IM, Rando TA. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle 2005;4(3):407-410.
73. Huang H, Kamm RD, Lee RT. Cell mechanics and mechanotransduction: pathways, probes, and physiology. Am J Physiol Cell Physiol 2004;287(1):C1-11.
74. Larsson T, Aspden RM, Heinegård D. Effects of mechanical load on cartilage matrix biosynthesis in vitro. Matrix 1991;11(6):388-394.
75. Plumb MS, Aspden RM. The response of elderly human articular cartilage to mechanical stimuli in vitro. Osteoarthr Cartilage 2005;13(12):1084-1091.
76. Plumb MS, Treon K, Aspden RM. Competing regulation of matrix biosynthesis by mechanical and IGF-1 signalling in elderly human articular cartilage in vitro. Biochim Biophys Acta 2006;1760(5):762-767.
77. Joaquin AM, Gollapudi S. Functional decline in aging and disease: a role for apoptosis. J Am Geriatr Soc 2001;49(9):1234-1240.
78. Kuhn K, D'Lima DD, Hashimoto S, Lotz M. Cell death in cartilage. Osteoarthr Cartilage 2004;12(1):1-16.
79. Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004;427:(suppl): S37-46.
80. Mobasheri A, Carter SD, Martin-Vasallo P, Shakibaei M. Integrins and stretch activated ion channels; putative components of functional cell surface mechanoreceptors in articular chondrocytes. Cell Biol Int 2002;26(1):1-18.
81. Adams CS, Horton WE Jr. Chondrocyte apoptosis increases with age in the articular cartilage of adult animals. Anat Rec 1998;250(4):418-425.
82. Kinkel MD, Yagi R, McBurney D, Nugent A, Horton WE Jr. Age-related expression patterns of Bag-1 and Bc1-2 in growth plate and articular chondrocytes. Anat Rec A Discov Mol Cell Evol Biol 2004;279(2):720-728.
83. Aigner T, Rose J, Martin J, Buckwalter J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res 2004;7(2):134-145.
84. Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O'Brien CA, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002;298(5594):843-846.
85. Scott JE, Bosworth TR, Cribb AM, Taylor JR. The chemical morphology of age-related changes in human intervertebral disc glycosaminoglycans from cervical, thoracic and lumbar nucleus pulposus and annulus fibrosus. J Anat 1994;184(1):73-82.
86. Lajeunesse D. The role of bone in the treatment of osteoarthritis. Osteoarthr Cartilage 2004;12(suppl A):S34-38.
87. Sims MR, Leppard PI, Sampson WJ, Dreyer CW. Microvascular luminal volume changes in aged mouse periodontal ligament. J Dent Res 1996;75(7):1503-1511.
88. Muller-Delp JM. Ageing induced adaptations of microvascular reactivity. Microcirculation 2006;13(4):301-314.